Literature DB >> 22157556

NCCN Clinical Practice Guidelines Occult primary.

David S Ettinger, Mark Agulnik, Justin M M Cates, Mihaela Cristea, Crystal S Denlinger, Keith D Eaton, Panagiotis M Fidias, David Gierada, Jon P Gockerman, Charles R Handorf, Renuka Iyer, Renato Lenzi, John Phay, Asif Rashid, Leonard Saltz, Lawrence N Shulman, Jeffrey B Smerage, Gauri R Varadhachary, Jonathan S Zager, Weining Ken Zhen.   

Abstract

Occult primary tumors, or cancers of unknown primary (CUPs), are defined as histologically proven metastatic malignant tumors whose primary site cannot be identified during pretreatment evaluation. They have a wide variety of clinical presentations and a poor prognosis in most patients. Patients with occult primary tumors often present with general complaints, such as anorexia and weight loss. Clinical absence of primary tumor, early dissemination, aggressiveness, and unpredictability of metastatic pattern are characteristic of these tumors. Life expectancy is very short, with a median survival of 6 to 9 months. In most patients, occult primary tumors are refractory to systemic treatments, and chemotherapy is only palliative and does not significantly improve long-term survival. However, certain clinical presentations of these tumors are associated with a better prognosis. Special pathologic studies can identify subsets of patients with tumor types that are more responsive to chemotherapy. Treatment options should be individualized for this selected group of patients to achieve improved response and survival rates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22157556     DOI: 10.6004/jnccn.2011.0117

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  17 in total

Review 1.  Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know.

Authors:  Kyung Won Kim; Katherine M Krajewski; Jyothi P Jagannathan; Mizuki Nishino; Atul B Shinagare; Jason L Hornick; Nikhil H Ramaiya
Journal:  AJR Am J Roentgenol       Date:  2013-03       Impact factor: 3.959

2.  A case of lung and mediastinal and hilar lymph node metastasis in a patient with cancer of unknown primary site.

Authors:  Shun-Kai Chang; Satoshi Ano; Norihiro Kikuchi; Michiko Masuda; Hajime Osawa; Yuzuru Kondo; Yukio Ishii
Journal:  Clin Exp Metastasis       Date:  2021-11-12       Impact factor: 5.150

3.  The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm.

Authors:  D Kaemmerer; N Posorski; F von Eggeling; G Ernst; D Hörsch; R P Baum; V Prasad; R Langer; I Esposito; G Klöppel; S Sehner; T Knösel; M Hommann
Journal:  Clin Exp Metastasis       Date:  2014-08-07       Impact factor: 5.150

4.  Subtle radiographic presentation of a pleural effusion secondary to a cancer of unknown primary: a case study.

Authors:  Marc-André Blanchette; Julie-Marthe Grenier
Journal:  J Can Chiropr Assoc       Date:  2014-09

5.  Metastatic melanoma of unknown primary in the temporalis muscle.

Authors:  Marco Dalle Carbonare; Mei Xien Goh; Zainab AlshiekhAli; David Howlett
Journal:  BMJ Case Rep       Date:  2017-10-20

6.  Surgical treatment of liver metastases in neuroendocrine neoplasms.

Authors:  Palepu Jagannath; Deepak Chhabra; Shailesh Shrikhande; Rajiv Shah
Journal:  Int J Hepatol       Date:  2012-01-26

7.  Practical guidelines for the surgical treatment of gallbladder cancer.

Authors:  Seung Eun Lee; Kyung Sik Kim; Wan Bae Kim; In-Gyu Kim; Yang Won Nah; Dong Hee Ryu; Joon Seong Park; Myung Hee Yoon; Jai Young Cho; Tae Ho Hong; Dae Wook Hwang; Dong Wook Choi
Journal:  J Korean Med Sci       Date:  2014-10-08       Impact factor: 2.153

8.  The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues.

Authors:  Nong Yang; Yi Li; Zhidong Liu; Hao Qin; Duanming Du; Xinkai Cao; Xiaoqing Cao; Jun Li; Dongge Li; Bo Jiang; Lincan Duan; Haiyan Yang; Zhenghua Zhang; Hao Lin; Jianying Li; Zhenhua Yang; Lei Xiong; Hua Shen; Lizhu Lin; Fugen Li
Journal:  BMC Cancer       Date:  2018-03-23       Impact factor: 4.430

9.  Surgical Strategy for T2 Gallbladder Cancer: Nationwide Multicenter Survey in Korea.

Authors:  Seung Eun Lee; Sun-Whe Kim; Ho-Seong Han; Woo Jung Lee; Dong-Sup Yoon; Baik-Hwan Cho; In Seok Choi; Hyun Jong Kim; Soon-Chan Hong; Sang-Mok Lee; Dong Wook Choi; Sang-Jae Park; Hong-Jin Kim; Jin-Young Jang
Journal:  J Korean Med Sci       Date:  2018-05-30       Impact factor: 2.153

10.  A Case of Gingival Metastasis from Rectal Cancer in Which Immunohistochemistry and PET-CT Were Useful for the Diagnostic Procedure.

Authors:  Masami Yamauchi; Katsunori Shinozaki; Mihoko Doi; Tomoko Nitta; Takashi Nishisaka
Journal:  Case Rep Oncol       Date:  2014-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.